Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / FEMY - FDA Approves IDE for the Pivotal Clinical Trial of Femasys' FemBloc Permanent Birth Control

FEMY - FDA Approves IDE for the Pivotal Clinical Trial of Femasys' FemBloc Permanent Birth Control

Femasys Inc.

2024-01-19 14:26:07 ET

(24/7 MARKET NEWS) – Femasys Inc. (NASDAQ: FEMY) reported, this morning, that the FDA approved...

For further details see:

FDA Approves IDE for the Pivotal Clinical Trial of Femasys’ FemBloc Permanent Birth Control
Stock Information
Company Name: Femasys Inc.
Stock Symbol: FEMY
Market: NASDAQ
Website: femasys.com
Menu
FEMY FEMY Quote FEMY Short FEMY News FEMY Articles FEMY Message Board
Get FEMY Alerts

News, Short Squeeze, Breakout and More Instantly...